Medicine and Dentistry
Autologous Bone Marrow Transplantation
100%
Bone Marrow Transplantation
100%
Busulfan
14%
Chronic Myelogenous Leukemia
100%
Cyclophosphamide
14%
Diseases
14%
Engraftment
28%
Hematopoietic Cell
14%
Immunoregulation
14%
Immunotherapy
14%
Interferon
14%
Long Term Survival
14%
Macrophage
14%
Metaphase
14%
Myeloid Leukemia
14%
Natural Killer Cell
14%
Necrosis
14%
Neoplasm
14%
Neutrophil
14%
Peripheral Edema
14%
Roquinimex
100%
Sweat Gland
14%
T Cell
14%
Transplantation
28%
Keyphrases
Accelerated Phase
25%
Acetylcholinesterase
12%
Allogeneic Bone Marrow Transplantation
100%
Blood Count
12%
Bone Marrow Cells
12%
Busulfan
12%
Chronic Myeloid Leukemia
100%
Chronic Phase
25%
Complete Cytogenetic Response
12%
Cyclophosphamide
12%
Cytogenetic Response
25%
Eccrine Sweat Gland
12%
Engraftment
25%
Graft-versus-host Disease (GvHD)
12%
Haematological Remission
12%
Hematopoietic Neoplasms
12%
Immune Regulation
12%
Interferon Therapy
12%
Long-term Survival
12%
Macrophage Activity
12%
Maximum Tolerated Dose
12%
Myeloid Leukemia
12%
Myelosuppressive Therapy
12%
Necrosis
12%
Neutrophils
12%
NK Cell Activity
12%
Peripheral Edema
12%
Ph Chromosome
12%
Ph-negative
25%
Ph-positive
25%
Phase II Study
12%
Reperfusion
12%
Skin Changes
12%
T Cells
12%
Twice Daily
12%
Pharmacology, Toxicology and Pharmaceutical Science
Busulfan
20%
Chronic Myeloid Leukemia
100%
Cyclophosphamide
20%
Diseases
20%
Immunotherapy
20%
Interferon
20%
Long Term Survival
20%
Myeloid Leukemia
20%
Necrosis
20%
Neoplasm
20%
Peripheral Edema
20%
Remission
20%
Roquinimex
100%
Immunology and Microbiology
Blood Cell Count
12%
Bone Marrow Transplantation
100%
Cyclophosphamide
12%
Engraftment
25%
Hematopoietic Cell
12%
Immunoregulation
12%
Immunotherapy
12%
interferon
12%
Long Term Survival
12%
Macrophage
12%
Maximum Permissible Dose
12%
Metaphase
12%
Myeloid
12%
Natural Killer Cell
12%
Neutrophil
12%
Roquinimex
100%
Sweat Gland
12%
T Cell
12%